Remodelling the injured CNS through the establishment of atypical ectopic perivascular neural stem cell niches

Archives Italiennes de Biologie

Volumn 148, Issue 2, 2010, Pages 173-183

  Pluchino, S ^a,c   Cusimano, M ^a   Bacigaluppi, M ^b   Martino, G ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Institute of Experimental Neurology   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atypical stem cell niches; CNS repair; Neural stem cells; Regenerative medicine; Stem cell therapies

Indexed keywords

ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; CYTOLOGY; DISEASE MODEL; HUMAN; IMMUNOLOGY; METHODOLOGY; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL NICHE; STEM CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; PROCEDURES;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; HUMANS; NEURONS; STEM CELL NICHE; STEM CELL TRANSPLANTATION; STEM CELLS;

PRIMATES; RODENTIA;

EID: 77955604948     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Aharonowiz M., Einstein O., Fainstein N., Lassmann H., Reubinoff B., Ben-Hur T. Neuroprotective effect of transplanted human embryonic stem cellderived neural precursors in an animal model of multiple sclerosis. PLoS ONE, 3: e3145, 2008.
2. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol., 153: 801-813, 1998.
3. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol., 5: 629-640, 2005.
4. Bacigaluppi M., Pluchino S., Jametti L.P., Kilic E., Kilic U., Salani G., Brambilla E., West M.J., Comi G., Martino G., Hermann D.M. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain, 132: 2239-2251, 2009.
5. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke, 28: 1233-1244, 1997.
6. Barres B.A., Hart I.K., Coles H.., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70: 31-46, 1992.
7. Ben-Shaanan T.L., Ben-Hur T., Yanai J. Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain. Mol. Psychiatry, 13: 222-231, 2008.
8. Block G.J., Ohkouchi S., Fung F., Frenkel J., Gregory C., Pochampally R., Dimattia G., Sullivan D.E., Prockop D.J. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells, 27: 670-681, 2009.
9. Bottai D., Madaschi L., Di Giulio A.M., Gorio A. Viability-dependent promoting action of adult neural precursors in spinal cord injury. Mol. Med., 14: 634-644, 2008.
10. Butzkueven H., Zhang J.G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., Kilpatrick T.J. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med., 8: 613-619, 2002.
11. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell, 11: 69-82, 2007.
12. Cannella B., Hoban C.J., Gao Y.L., Garcia-Arenas R., Lawson D., Marchionni M., Gwynne D., Raine C.S. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc. Natl. Acad. Sci. U S A, 95:10100-10105, 1998.
13. Canoll P.D., Musacchio J.M., Hardy R., Reynolds R., Marchionni M.A., Salzer J.L. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron, 17: 229-243, 1996.
14. Canoll P.D., Kraemer R., Teng K.K., Marchionni M.A., Salzer J.L. GGF/neuregulin induces a phenotypic reversion of oligodendrocytes. Mol. Cell. Neurosci., 13: 79-94, 1999.
15. Capone C., Frigerio S., Fumagalli S., Gelati M., Principato M.C., Storini C., Montinaro M., Kraftsik R., De Curtis M., Parati E., De Simoni M.G. Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS ONE, 2: e373, 2007.
16. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., Lu M., Gautam S.C., Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res., 73: 778-786, 2003.
17. Chu K., Kim M., Park K.I., Jeong S.W., Park H.K., Jung K.H., Lee S.T., Kang L., Lee K., Park D.K., Kim S.U., Roh J.K. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res., 1016: 145-153, 2004.
18. Einstein O., Karussis D., Grigoriadis N., Mizrachi- Kol R., Reinhartz E., Abramsky O., Ben-Hur T. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol. Cell. Neurosci., 24: 1074-1082, 2003.
19. Einstein O., Grigoriadis N., Mizrachi-Kol R., Reinhartz E., Polyzoidou E., Lavon I., Milonas I., Karussis D., Abramsky O., Ben-Hur T. Transplanted neural precursorcells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp. Neurol., 198: 275-284, 2006.
20. Einstein O., Fainstein N., Vaknin I., Mizrachi-Kol R., Reihartz E., Grigoriadis N., Lavon I., Baniyash M., Lassmann H., Ben-Hur T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol., 61: 209-218, 2007.
21. Einstein O. and Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch. Neurol., 65: 452-456, 2008.
22. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J., Wood S., Wenger D.A., Pietryga D., Wall D., Champagne M., Morse R., Krivit W., Kurtzberg J. Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease. N. Engl. J. Med., 352: 2069-2081, 2005.
23. Ferrer-Alcon M., Winkler-Hirt C., Perrin F.E., Kato A.C. Grafted neural stem cells increase the life span and protect motoneurons in pmn mice. Neuroreport, 18: 1463-1468, 2007.
24. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., Ellwart J.W., Willem M., Lassmann H., Wekerle H. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity, 14: 547-560, 2001.
25. Franklin R.J. Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci., 3: 705-714, 2002.
26. Franklin R.J. and Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci., 9: 839-855, 2008.
27. Fujiwara Y., Tanaka N., Ishida O., Fujimoto Y., Murakami T., Kajihara H., Yasunaga Y., Ochi M. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett., 366: 287-291, 2004.
28. Garbuzova-Davis S., Willing A.E., Zigova T., Saporta S., Justen E.B., Lane J.C., Hudson J.E., Chen N., Davis C.D., Sanberg P.R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J. Hematother. Stem Cell Res., 12: 255-270, 2003.
29. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat. Med., 8: 1363-1368, 2002.
30. Hattiangady B., Shuai B., Cai J., Coksaygan T., Rao M.S., Shetty A.K. Increased dentate neurogenesis after grafting of glial restricted progenitors or neural stem cells in the aging hippocampus. Stem Cells, 25: 2104-2117, 2007.
31. Jin K., Wang X., Xie L., Mao X.O., Zhu W., Wang Y., Shen J., Mao Y., Banwait S., Greenberg D.A. Evidence for stroke-induced neurogenesis in the human brain. Proc. Natl. Acad. Sci. U S A, 103: 13198-13202, 2006.
32. Kamei N., Tanaka N., Oishi Y., Hamasaki T., Nakanishi K., Sakai N., Ochi M. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures. Spine, 32: 1272-1278, 2007.
33. Kerr D.A., Llado J., Shamblott M.J., Maragakis N.J., Irani D.N., Crawford T.O., Krishnan C., Dike S., Gearhart J.D., Rothstein J.D. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J. Neurosci., 23: 5131-5140, 2003.
34. Lee S.T., Chu K., Jung K.H., Kim S.J., Kim D.H., Kang K.M., Hong N.H., Kim J.H., Ban J.J., Park H.K., Kim S.U., Park C.G., Lee S.K., Kim M., Roh J.K. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain, 131: 616-629, 2008.
35. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med., 8: 620-624, 2002.
36. Liu H., Honmou O., Harada K., Nakamura K., Houkin K., Hamada H., Kocsis J.D. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain, 129: 2734-2745, 2006.
37. Lu P., Jones L.L., Snyder E.Y., Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol., 181: 115-129, 2003.
38. Madhavan L., Ourednik V., Ourednik J. Neural stem/ progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression. Stem Cells, 26: 254-265, 2008.
39. Martino G. How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders. Lancet Neurol., 3: 372-378, 2004.
40. Martino G. and Pluchino S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci., 7: 395-406, 2006.
41. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci., 20: 5703-5708, 2000.
42. Muller F.J., Snyder E.Y., Loring J.F. Gene therapy: can neural stem cells deliver? Nat. Rev. Neurosci., 7: 75-84, 2006.
43. Munoz J.R., Stoutenger B.R., Robinson A.P., Spees J.L., Prockop D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. U S A, 102: 18171-18176, 2005.
44. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol., 20: 1103-1110, 2002.
45. Park K.I., Ourednik J., Ourednik V., Taylor R.M., Aboody K.S., Auguste K.I., Lachyankar M.B., Redmond D.E., Snyder E.Y. Global gene and cell replacement strategies via stem cells. Gene Ther., 9: 613-624, 2002a.
46. Park K.I., Teng Y.D., Snyder E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol., 20: 1111-1117, 2002b.
47. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature, 422: 688-694, 2003.
48. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature, 436: 266-271, 2005.
49. Pluchino S. and Martino G. Neural stem cell-mediated immunomodulation: repairing the haemorrhagic brain. Brain, 131: 604-605, 2008.
50. Pluchino S., Muzio L., Imitola J., Deleidi M., Alfaro- Cervello C., Salani G., Porcheri C., Brambilla E., Cavasinni F., Bergamaschi A., Garcia-Verdugo J.M., Comi G., Khoury S.J., Martino G. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain, 131: 2564-2578, 2008.
51. Pluchino S., Gritti A., Blezer E., Amadio S., Brambilla E., Borsellino G., Cossetti C., Del Carro U., Comi G., t Hart B., Vescovi A., Martino G. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann. Neurol., 66: 343-354, 2009a.
52. Pluchino S., Zanotti L., Brambilla E., Rovere-Querini P., Capobianco A., Alfaro-Cervello C., Salani G., Cossetti C., Borsellino G., Battistini L., Ponzoni M., Doglioni C., Garcia-Verdugo J.M., Comi G., Manfredi A.A., Martino G. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One, 4: e5959, 2009b.
53. Pluchino S., Zanotti L., Brini E., Ferrari S., Martino G. Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci. Lett., 456: 101-106, 2009c.
54. Rampon C., Weiss N., Deboux C., Chaverot N., Miller F., Buchet D., Tricoire-Leignel H., Cazaubon S., Baron-Van Evercooren A., Couraud P.O. Molecular mechanism of systemic delivery of neural precursor cells to the brain: assembly of brain endothelial apical cups and control of transmigration by CD44. Stem Cells, 26: 1673-1682, 2008.
55. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A.I., Zhao R.C., Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2: 141-150, 2008.
56. Ruffini F., Furlan R., Poliani P.L., Brambilla E., Marconi P.C., Bergami A., Desina G., GloriosoJ.C., Comi G., Martino G. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther., 8: 1207-1213, 2001.
57. Suzuki M., McHugh J., Tork C., Shelley B., Klein S.M., Aebischer P., Svendsen C.N. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE, 2: e689, 2007.
58. Takeuchi H., Natsume A., Wakabayashi T., Aoshima C., Shimato S., Ito M., Ishii J., Maeda Y., Hara M., Kim S.U., Yoshida J. Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGFdependent manner. Neurosci. Lett., 426: 69-74, 2007.
59. Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., Langer R., Snyder E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. U S A, 99: 3024-3029, 2002.
60. Thored P., Wood J., Arvidsson A., Cammenga J., Kokaia Z., Lindvall O. Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke, 38: 3032-3039, 2007.
61. Villoslada P., Hauser S.L., Bartke I., Unger J., Heald N., Rosenberg D., Cheung S.W., Mobley W.C., Fisher S., Genain C.P. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med., 191: 1799 - 1806, 2000.
62. Xiao J., Nan Z., Motooka Y., Low W.C. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev., 14: 722-733, 2005.
63. Yan J., Welsh A.M., Bora S.H., Snyder E.Y., Koliatsos V.E. Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J. Comp. Neurol., 480: 101-114, 2004.
64. Yao D.L., Liu X., Hudson L.D., Webster H.D. Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis. Life Sci., 58: 1301-1306, 1996.
65. Yoo S.W., Kim S.S., Lee S.Y., Lee H.S., Kim H.S., Lee Y.D., Suh-Kim H. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med., 40: 387-397, 2008.
66. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106: 1755-1761, 2005.
67. Ziv Y., Avidan H., Pluchino S., Martino G., Schwartz M. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc. Natl. Acad. Sci. U S A, 103: 13174-13179, 2006